Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
paracetamol + methylephedrine
- Development stage
- Unknown
- Lead developer
- Jiangxi Provincial Children's Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Compound Paracetamol and Methylephedrine Oral Solution is a fixed-dose combination small-molecule drug formulated as an oral solution for pediatric use, primarily in China. It contains two active ingredients: paracetamol (acetaminophen), a non-opioid analgesic and antipyretic that acts by inhibiting cyclooxygenase (COX) enzymes to reduce fever and pain, and methylephedrine, a sympathomimetic agent that acts on alpha- and beta-adrenergic receptors to relieve nasal congestion and bronchospasm. The drug is indicated for the symptomatic treatment of upper respiratory tract infections (URTI) and influenza in pediatric patients. It is currently being evaluated in large-scale multicenter observational cohort registry studies in China to assess its real-world safety and effectiveness compared to other compound pediatric cold medicines.
- Brand names
- Compound Paracetamol and Methylephedrine Oral Solution
- Other names
- acetaminophen + methylephedrineparacetamol and methylephedrine hydrochloride
02
Targets
ADRB1 (β1)ADRA1A (α1A)
Beyond the preview
Go deeper on paracetamol + methylephedrine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on paracetamol + methylephedrine.